CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.

Five U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo ...

A life sciences company has sold off part of its business that includes a Morrisville facility with hundreds of workers.

Shares of Catalent, Inc. (NYSE:CTLT – Get Free Report) have received an average recommendation of “Hold” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. Eight ...

On Monday, Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $60.65 which represents a slight increase of $0.20 or 0.33% from the prior close of $60.45. The stock opened at $60.5 and ...

Catalent (CTLT) sells Somerset, NJ facility to Ardena. Corporate headquarters to shift to new location post-transition.

On Thursday, Catalent Inc (CTLT) stock saw a decline, ending the day at $60.71 which represents a decrease of $-0.25 or -0.41% from the prior close of $60.96. The stock opened at $60.78 and touched a ...

Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, ...

Below is Validea's guru fundamental report for CATALENT INC (CTLT). Of the 22 guru strategies we follow, CTLT rates highest using our Value Investor model based on the published strategy of ...

Catalent, Inc. (CTLT), a provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer ...

(Reuters) - Catalent (NYSE: CTLT) has agreed to sell its oral drug development and small-scale manufacturing facility in ...